corporate and local contribution of pfizer to smoking cessation josé aleixo dias medical director...
TRANSCRIPT
Corporate and local Corporate and local contribution of Pfizer to contribution of Pfizer to
Smoking Cessation Smoking Cessation
José Aleixo DiasJosé Aleixo Dias
Medical Director – Pfizer, PortugalMedical Director – Pfizer, Portugal
TOPICSTOPICS
• Pfizer is very proud of sponsoring the European Network of Quitlines (ENQ)
• Partnerships in place between Pfizer and ENQ• Pfizer Worldwide commitment to smoking
cessation and drug development• Pfizer contribution to smoking cessation in
Portugal: • The relevance of the problem and smoker’s
behavioural patterns
• Education and training in smoking cessation
• Tobacco associated costs
• Think Tank: Portugal Sem Fumo
• Partnerships
• Public awareness campaigns
Partnerships in place between Pfizer Partnerships in place between Pfizer and ENQand ENQ
TOPICSTOPICS
Partnerships in place between Pfizer and ENQ:
• Direct to smokers activities
• The eastern European program on social exclusion
• The smoke free awards
Pfizer Worldwide commitment to Pfizer Worldwide commitment to smoking cessation and drug smoking cessation and drug
developmentdevelopment
6
Pfizer Worldwide commitment to smoking cessation Pfizer Worldwide commitment to smoking cessation and drug developmentand drug development
Smoking
Cessation
Smoking
Cessation
Pfizer contribution to smoking cessation in PortugalPfizer contribution to smoking cessation in Portugal
The relevance of the problem and The relevance of the problem and smoker’s behavioural patternssmoker’s behavioural patterns
Direccionamos objectivos.
Studies:Studies:
Smoker motivation (Motivação do Fumador)
© Novadir study report for Pfizer
December 2006
Pfizer contribution to smoking cessation in PortugalPfizer contribution to smoking cessation in Portugal
Education and training in smoking Education and training in smoking cessationcessation
Tobacco Law n.º 37/2007Tobacco Law n.º 37/2007
Education and training in Smoking Education and training in Smoking CessationCessationEducation and training in Smoking Education and training in Smoking CessationCessation
Tobbacco cessation consultations
Update version of Smoking Cessation Update version of Smoking Cessation GuideGuide
Update version of Smoking Cessation Update version of Smoking Cessation GuideGuide
Unal B et al. BMJ 2005;331:1–6.
Avoidable deaths due to Coronary Heart Avoidable deaths due to Coronary Heart Disease in England & Wales, attributable to Disease in England & Wales, attributable to risk factor changesrisk factor changes
Deixar de fumar
0
5.000
10.000
15.000
20.000
25.000
30.000
35.000
Mor
tes
evita
das
ou a
diad
as (N
)
Colesterol reduction
Blood Pressure reduction
24,680
47107235
Smoking cessation
Avoid
able
death
s (n
um
ber)
0
Reimbursement (€) - 2008
305 millions
99 millions
Contribution of National & International Contribution of National & International Experts Experts
April 15th, 2008
“… the nature and potential intensity of clinical effects caused by tobacco are not less than those caused by alcohol or opiates”.
“Relapse from quitting back to smoking is higher with tobacco than with alcohol or other drugs”.
Serena Tonstad, Professor Serena Tonstad, Professor Director of Preventive CareDirector of Preventive CareSchool of Public HealthSchool of Public Health Loma Linda UniversityLoma Linda University
Pfizer contribution to smoking cessation in PortugalPfizer contribution to smoking cessation in Portugal
Tobacco associated costsTobacco associated costs
Tobacco associated costs in PortugalTobacco associated costs in Portugal
Conclusions:Conclusions:
The global cost to the Health System in 2005 was estimated to be: 436 millions €uros.
Income from taxation over tobacco during the same year was of 1323 millions €uros.
Pfizer contribution to smoking cessation in PortugalPfizer contribution to smoking cessation in Portugal
Think Tank: Smoke Free Portugal Think Tank: Smoke Free Portugal ((Portugal Sem Fumo)Portugal Sem Fumo)
Pfizer contribution to smoking cessation in PortugalPfizer contribution to smoking cessation in Portugal
PartnershipsPartnerships
Partnerships: APMCG & MISSION for Primary CarePartnerships: APMCG & MISSION for Primary Care
Fellowship on “Fellowship on “Good multidisciplinar collaboration Good multidisciplinar collaboration in Smoking Cessation at the Primary Care levelin Smoking Cessation at the Primary Care level” ”
( Bolsa de Boas Práticas em Colaboração Multidisciplinar Cuidados de Saúde Primários)
Partnerships: Nat.Association of Pharmacies (ANF)
Pfizer contribution to smoking cessation in PortugalPfizer contribution to smoking cessation in Portugal
Public awareness campaignsPublic awareness campaigns
Smoke Free DaySmoke Free Day
Smoke Free DaySmoke Free Day
Manual of good practices in managing smoking cessationManual of good practices in managing smoking cessation
Public awareness campaigns
Public awareness campaigns
